A-HERO - A-HERO - Antihelmintic Research and Optimisation


Jennifer Keiser

Jennifer Keiser, Associate Professor, PhD
Head of Unit


Project Facts

Lo N.C, Coulibaly J.T, Bendavid E, N'Goran E.K, Utzinger J, Keiser J, Bogoch II, Andrews J.R. Evaluation of a urine pooling strategy for the rapid and cost-efficient prevalence classification of schistosomiasis. PLoS Negl Trop Dis. 2016;10(8):e0004894. DOI: 10.1371/journal.pntd.0004894

Liu Z, Xia B, Saric J, Utzinger J, Holmes E, Keiser J, Li J.V. Effects of vancomycin and ciprofloxacin on the NMRI mouse metabolism. J Proteome Res. 2018;17(10):3565-3573. DOI: 10.1021/acs.jproteome.8b00583

Meister I, Leonidova A, Kovac J, Duthaler U, Keiser J, Hawyler J. Development and validation of an enantioselective LM-MS/MS method for the analysis of the anthelmintic drug praziquantel and its main metabolite in human plasma, blood and dried blood spots. J Pharm Biomed Anal. 2016;118:81-88. DOI: 10.1016/j.jpba.2015.10.011

Speich B, Croll D, Fürst T, Utzinger J, Keiser J. Effect of sanitation and water treatment on intestinal protozoa infection: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16(1):87-99. DOI: 10.1016/S1473-3099(15)00349-7

Wang C, Zhao Q, Vergas M, Jones J.O, White K.L, Shackleford D.M, Chen G, Saunders J, Ng A.C.F, Chiu F.C.K, Dong Y, Charman S.A, Keiser J, Vennerstrom J.L. Revisiting the SAR of the antischistosomal aryl hydantoin (Ro 13-3978). J Med Chem. 2016;59:10705-10718. DOI: 10.1021/acs.jmedchem.6b01410

Barda B, Coulibaly J.T, Puchkov M, Huwyler J, Hattendorf J, Keiser J. Efficacy and safety of moxidectin, synriam, synriam-praziquantel versus praziquantel against Schistosoma haematobium and S. mansoni infections: a randomized, exploratory phase 2 trial. PLoS Negl Trop Dis. 2016;10(9):e0005008. DOI: 10.1371/journal.pntd.0005008

Meister I, Kovac J, Duthaler U, Odermatt P, Huwyler J, Vanobberghen F, Sayasone S, Keiser J. Pharmacokinetic study of praziquantel enantiomers and its main metabolite R-trans-4-OH-PZQ in plasma, blood and dried blood spots in Opisthorchis viverrini-infected patients. PLoS Negl Trop Dis. 2016;10(5):e0004700. DOI: 10.1371/journal.pntd.0004700

Keiser J, Panic G, Adelfio R, Cowan N, Vargas M, Scandale I. Evaluation of an FDA approved library against laboratory models of human intestinal nematode infections. Parasit Vectors. 2016;9:376. DOI: 10.1186/s13071-016-1616-0

Cowan N, Raimondo A, Keiser J. Approved oncology drugs lack in vivo activity against Trichuris muris despite in vitro activity. Parasitol Res. 2016;115(11):4443-4446. DOI: 10.1007/s00436-016-5225-9

Cowan N, Vargas M, Keiser J. In vitro and in vivo drug interaction study of two lead combinations, oxantel pamoate plus albendazole and albendazole plus mebendazole, for the treatment of soil-transmitted helminthiasis. Antimicrob Agents Chemother. 2016;60(10):6127-6133. DOI: 10.1128/AAC.01217-16

Khan M.O, Keiser J, Amoyaw P.N, Hossain M.F, Vargas M, Le J.G, Simpson N.C, Roewe K.D, Freeman T.N, Hasley T.R, Maples R.D, Archibald S.J, Hubin T.J. Discovery of antischistosomal drug leads based on tetraazamacrocyclic derivatives and their metal complexes. Antimicrob Agents Chemother. 2016;60(9):5331-5336. DOI: 10.1128/AAC.00778-16

Clède S, Cowan N, Lambert F, Bertrand H.C, Rubbiani R, Patra M, Hess J, Sandt C, Trcera N, Gasser G, Keiser J, Policar C. Bimodal X-ray and infrared imaging of an organometallic derivative of praziquantel in Schistosoma mansoni. Chembiochem. 2016;17(11):1004-1007. DOI: 10.1002/cbic.201500688

Panic G, Flores D, Ingram-Sieber K, Keiser J. Fluorescence/luminescence-based markers for the assessment of Schistosoma mansoni schistosomula drug assays. Parasit Vectors. 2015;8:624. DOI: 10.1186/s13071-015-1233-3

Flores D, Panic G, Braissant O, Keiser J. A novel isothermal microcalorimetry tool to assess drug effects on Ancylostoma ceylanicum and Necator americanus. Appl Microbiol Biotechnol. 2016;100(2):837-846. DOI: 10.1007/s00253-015-7081-4

Keiser J. Is Caenorhabditis elegans the magic bullet for anthelminthic drug discovery?. Trends Parasitol. 2015;31(10):455-456. DOI: 10.1016/j.pt.2015.08.004

Qian M.-B, Utzinger J, Keiser J, Zhou X.-N. Clonorchiasis. Lancet. 2016;387(10020):800-810. DOI: 10.1016/S0140-6736(15)60313-0

Cowan N, Keiser J. Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni. Parasit Vectors. 2015;8:417. DOI: 10.1186/s13071-015-1023-y

Panic G, Vargas M, Scandale I, Keiser J. Activity profile of an FDA-approved compound library against Schistosoma mansoni. PLoS Negl Trop Dis. 2015;9(7):e0003962. DOI: 10.1371/journal.pntd.0003962

Vejzagic N, Adelfio R, Keiser J, Kringel H, Thamsborg S.M, Kapel C.M. Bacteria-induced egg hatching differs for Trichuris muris and Trichuris suis. Parasit Vectors. 2015;8:371. DOI: 10.1186/s13071-015-0986-z

Hess J, Keiser J, Gasser G. Toward organometallic antischistosomal drug candidates. Future Med Chem. 2015;7(6):821-830. DOI: 10.4155/fmc.15.22

Cowan N, Yaremenko I.A, Krylov I, Terent'ev A.O, Keiser J. Elucidation of the in vitro and in vivo activities of bridged 1,2,4-trioxolanes, bridged 1,2,4,5-tetraoxanes, tricyclic monoperoxides, silyl peroxides, and hydroxylamine derivatives against Schistosoma mansoni.. Bioorg Med Chem. 2015;23(16):5175-5181. DOI: 10.1016/j.bmc.2015.02.010

Keiser J, Panic G, Vargas M, Wang C, Dong Y, Gautam N, Vennerstrom J.L. Aryl hydantoin Ro 13-3978, a broad-spectrum antischistosomal. J Antimicrob Chemother. 2015;70(6):1788-1797. DOI: 10.1093/jac/dkv016

Cowan N, Datwyler P, Ernst B, Wang C, Vennerstrom J.L, Spangenberg T, Keiser J. Activities of N,N' -diarylurea MMV665852 analogs against Schistosoma mansoni. Antimicrob Agents Chemother. 2015;59(4):1935-1941. DOI: 10.1128/AAC.04463-14

Panic G, Duthaler U, Speich B, Keiser J. Repurposing drugs for the treatment and control of helminth infections. Int J Parasitol Drugs Drug Resist. 2014;4:185-200. DOI: 10.1016/j.ijpddr.2014.07.002

Spivak A.Y, Keiser J, Vargas M, Gubaidullin R.R, Nedopekina D.A, Shakurova E.R, Khalitova R.R, Odinokov V.N. Synthesis and activity of new triphenylphosphonium derivatives of betulin and betulinic acid against Schistosoma mansoni in vitro and in vivo. Bioorg Med Chem. 2014;22(21):6297-6304. DOI: 10.1016/j.bmc.2014.07.014

Keiser J, Vargas M, Rubbiani R, Gasser G, Biot C. In vitro and in vivo antischistosomal activity of ferroquine derivatives. Parasit Vectors. 2014;7:424. DOI: 10.1186/1756-3305-7-424

Meister I, Ingram-Sieber K, Cowan N, Todd M, Robertson M.N, Meli C, Patra M, Gasser G, Keiser J. Activity of praziquantel enantiomers and main metabolites against Schistosoma mansoni. Antimicrob Agents Chemother. 2014;58(9):5466-5472. DOI: 10.1128/AAC.02741-14